Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16381046rdf:typepubmed:Citationlld:pubmed
pubmed-article:16381046lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:16381046lifeskim:mentionsumls-concept:C0080188lld:lifeskim
pubmed-article:16381046lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:16381046pubmed:issue2lld:pubmed
pubmed-article:16381046pubmed:dateCreated2006-2-7lld:pubmed
pubmed-article:16381046pubmed:abstractTextTwo tetrasaccharides carrying the trisaccharidic Lewis x motif on a GlcNAc or a Gal residue were produced on the gram-scale by high-cell-density cultures of metabolically engineered Escherichia coli strains that overexpressed the Helicobacter pylori futA gene for alpha-3 fucosyltransferase and the Neisseria meningitidis lgtB gene for beta-4 galactosyltransferase. The first compound Galbeta-4(Fucalpha-3)GlcNAcbeta-4GlcNAc was produced by glycosylation of chitinbiose, which was endogenously generated in the bacterial cytoplasm by the successive action of the rhizobial chitin-synthase NodC and the Bacillus circulans chitinase A1, whose genes were additionally expressed in the E. coli strain. The second compound, Galbeta-4(Fucalpha-3)GlcNAcbeta-3Gal, was produced from exogenously added Gal by a strain that was deficient in galactokinase activity and overexpressed the additional N. meningitidis lgtA gene for beta-3 N-acetylglucosaminyltransferase.lld:pubmed
pubmed-article:16381046pubmed:languageenglld:pubmed
pubmed-article:16381046pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16381046pubmed:citationSubsetIMlld:pubmed
pubmed-article:16381046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16381046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16381046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16381046pubmed:statusMEDLINElld:pubmed
pubmed-article:16381046pubmed:monthFeblld:pubmed
pubmed-article:16381046pubmed:issn1439-4227lld:pubmed
pubmed-article:16381046pubmed:authorpubmed-author:UtilleJean...lld:pubmed
pubmed-article:16381046pubmed:authorpubmed-author:HeyraudAlainAlld:pubmed
pubmed-article:16381046pubmed:authorpubmed-author:SamainEricElld:pubmed
pubmed-article:16381046pubmed:authorpubmed-author:BossoClaudeClld:pubmed
pubmed-article:16381046pubmed:authorpubmed-author:DumonClaireClld:pubmed
pubmed-article:16381046pubmed:issnTypePrintlld:pubmed
pubmed-article:16381046pubmed:volume7lld:pubmed
pubmed-article:16381046pubmed:ownerNLMlld:pubmed
pubmed-article:16381046pubmed:authorsCompleteYlld:pubmed
pubmed-article:16381046pubmed:pagination359-65lld:pubmed
pubmed-article:16381046pubmed:meshHeadingpubmed-meshheading:16381046...lld:pubmed
pubmed-article:16381046pubmed:meshHeadingpubmed-meshheading:16381046...lld:pubmed
pubmed-article:16381046pubmed:meshHeadingpubmed-meshheading:16381046...lld:pubmed
pubmed-article:16381046pubmed:meshHeadingpubmed-meshheading:16381046...lld:pubmed
pubmed-article:16381046pubmed:meshHeadingpubmed-meshheading:16381046...lld:pubmed
pubmed-article:16381046pubmed:meshHeadingpubmed-meshheading:16381046...lld:pubmed
pubmed-article:16381046pubmed:year2006lld:pubmed
pubmed-article:16381046pubmed:articleTitleProduction of Lewis x tetrasaccharides by metabolically engineered Escherichia coli.lld:pubmed
pubmed-article:16381046pubmed:affiliationCentre de Recherches sur les Macromolécules Végétales, ICMG, FR CNRS-UJF 2607, B P 53, 38041 Grenoble Cedex 9, France.lld:pubmed
pubmed-article:16381046pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16381046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16381046lld:pubmed